These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7536864

  • 1. In vitro purging with BCR-ABL antisense oligodeoxynucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantation.
    de Fabritis P, Amadori S, Petti MC, Mancini M, Montefusco E, Picardi A, Geiser T, Campbell K, Calabretta B, Mandelli F.
    Leukemia; 1995 Apr; 9(4):662-4. PubMed ID: 7536864
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantation.
    Yuan T, Zhou YQ, Herst CV, Reading C, Ellersen D, Etkin M, Khouri I, Kantarjian H, Talpaz M, Deisseroth A.
    Prog Clin Biol Res; 1992 Apr; 377():227-30. PubMed ID: 1438419
    [No Abstract] [Full Text] [Related]

  • 8. Selection of BCR/ABL-negative progenitor cells from chronic myeloid leukemia marrow.
    Leemhuis T, Leibowitz D, Cox G, Srour EF, Tricot G, Hoffman R.
    Prog Clin Biol Res; 1992 Apr; 377():231-7. PubMed ID: 1279706
    [No Abstract] [Full Text] [Related]

  • 9. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L, Lalle M, Pandolfi A, Ruscio C, Amodeo R.
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [Abstract] [Full Text] [Related]

  • 10. Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells.
    de Fabritiis P, Skorski T, De Propris MS, Paggi MG, Nieborowska-Skorska M, Lisci A, Buffolino S, Campbell K, Geiser T, Calabretta B.
    Leukemia; 1997 Jun; 11(6):811-9. PubMed ID: 9177433
    [Abstract] [Full Text] [Related]

  • 11. Elimination of clonogenic Philadelphia-positive cells using BCR-ABL antisense oligodeoxynucleotides.
    de Fabritiis P, Amadori S, Calabretta B, Mandelli F.
    Bone Marrow Transplant; 1993 Sep; 12(3):261-5. PubMed ID: 8241986
    [Abstract] [Full Text] [Related]

  • 12. The use of cultured bone marrow cells in autologous transplantation.
    Coutinho LH, Testa NG, Chang J, Morgenstern G, Harrison C, Dexter TM.
    Prog Clin Biol Res; 1990 Sep; 333():415-32; discussion 433. PubMed ID: 2408062
    [Abstract] [Full Text] [Related]

  • 13. Treatment of chronic myelogenous leukemia (CML) with c-myb antisense oligodeoxynucleotides.
    Gewirtz AM.
    Bone Marrow Transplant; 1994 Sep; 14 Suppl 3():S57-61. PubMed ID: 7697011
    [No Abstract] [Full Text] [Related]

  • 14. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Cottafavi L, Dotti GP, Rizzoli V.
    Bone Marrow Transplant; 1994 Sep; 14(3):425-32. PubMed ID: 7994267
    [Abstract] [Full Text] [Related]

  • 15. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
    Ericson SG, Colby E, Welch L, Ball ED.
    Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
    [Abstract] [Full Text] [Related]

  • 16. Prompt haemopoietic reconstitution following hyperthermia purged autologous marrow and peripheral blood stem cell transplantation in acute myeloid leukaemia.
    Herrmann RP, O'Reilly J, Meyer BF, Lazzaro G.
    Bone Marrow Transplant; 1992 Sep; 10(3):293-5. PubMed ID: 1358379
    [Abstract] [Full Text] [Related]

  • 17. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
    Yang H, Eaves C, de Lima M, Lee MS, Champlin RE, McMannis JD, Robinson SN, Niu T, Decker WK, Xing D, Ng J, Li S, Yao X, Eaves AC, Jones R, Andersson BS, Shpall EJ.
    Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011
    [Abstract] [Full Text] [Related]

  • 18. c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
    Rosti V, Bergamaschi G, Ponchio L, Cazzola M.
    Leukemia; 1992 Jan; 6(1):1-7. PubMed ID: 1736009
    [Abstract] [Full Text] [Related]

  • 19. In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.
    Carlo-Stella C, Mangoni L, Piovani G, Almici C, Garau D, Caramatti C, Rizzoli V.
    Bone Marrow Transplant; 1991 Oct; 8(4):265-73. PubMed ID: 1756324
    [Abstract] [Full Text] [Related]

  • 20. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D, Labar B, Bogdanic V, Skodlar J, Petrovecki M, Mrsic M, Maravic N, Sneller V, Radman I, Kovacevic-Metelko J.
    Wien Med Wochenschr; 1995 Oct; 145(2-3):61-4. PubMed ID: 7762256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.